医用酶技术市场概况、增长、趋势、分析、研究报告(2020-2028 年)

  • Report Code : TIPRE00020828
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 231
Buy Now

Medical Enzyme Technology Market to Grow at a CAGR of 6.7% to reach US$ 6,700.00 million from 2020 to 2028

Buy Now

 

预计医用酶技术的价值将从 2020 年的 40.1257 亿美元增至 2028 年的 67 亿美元;预计2021 年至 2028 年的复合年增长率为 6.7%

 

医疗酶技术市场已根据酶的类型、应用和地区进行了分析。根据地区划分的市场分为北美、欧洲、亚太地区、中东和非洲以及南美和中美。该报告强调市场趋势、技术进步、市场动态和领先公司竞争格局分析等参数,以提供对医疗酶技术市场的见解和深入分析。它还包括对所有主要地区市场 COVID-19 疫情的分析。

 

市场洞察

 

 

酶工程进展将成为医用酶技术市场的主要趋势

 

酶工程在生物技术、生命科学和生物医学高效生物催化剂的开发中起着重要作用。酶工程是通过改变氨基酸序列来定制具有改进性能的新生物催化剂的过程。尽管可能的改变非常多,但这一过程已经取得了显著的成果,即独特的酶设计和优化,可用于化学和药物生物合成、再生医学、食品生产、废物生物降解生物传感

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

医用酶技术市场:

医用酶技术市场
  • Medical Enzyme Technology Market
    复合年增长率(2020 - 2028 年)
    6.7%
  • 2020 年市场规模
    40.1 亿美元
  • 2028 年市场规模
    67 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 默克
  • 赛默飞世尔科技公司
  • 诺维信
  • 武田药品工业株式会社
  • 安捷伦科技公司
  • 丹纳赫(Cytiva)
  • 赛诺菲
  • 旭化成公司
  • 普洛麦格公司

区域概况

Medical Enzyme Technology Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Medical Enzyme Technology Market酶类型
  • 消化酶
  • 溶栓酶
  • 水解酶
  • 核酸内切酶
Medical Enzyme Technology Market应用
  • 疾病治疗
  • 诊断工具
  • 生物医学研究
  • 其他的
Medical Enzyme Technology Market地理
  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲和中美洲
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

除了经典的合理设计和定向进化方法外,机器学习 (ML) 方法也越来越多地用于在数据中寻找模式,以帮助预测蛋白质结构;改善酶的稳定性、溶解度和功能;预测底物特异性;并指导合理的蛋白质设计。机器学习是设计新生物催化剂的第三种方法,在过去几十年中一直受到关注。与模型驱动的合理设计方法不同,该策略是数据驱动的,因为它可以识别现有数据中的模式来预测未知但相似的输入的属性。2020 年 1 月,产品和服务提供商 Curative Enzymes 推出了酶工程和改造服务,以帮助主要客户。

随着重组和改造酶的新技术和方法的出现,蛋白质工程工作变得更加方便,为工业应用带来了新的半合成或合成生物催化剂和分子。因此,酶工程的进步很可能成为预测期内市场的一个普遍趋势。

 

基于酶类型的见解

 

医疗酶技术市场按酶类型细分为消化酶、血栓溶解酶、水解酶和核酸内切酶。水解酶细分市场在 2020 年占据了最大的市场份额;此外,预计血栓溶解酶细分市场在预测期内的复合年增长率最高,为 7.2%。

 

基于应用的洞察

 

医疗酶技术市场按应用细分为疾病治疗、诊断工具、生物医学研究等。疾病治疗领域在 2020 年占据了最大的市场份额,预计同一领域在预测期内将实现 7.1% 的最高复合年增长率。

在医用酶技术市场运营的公司正在采用产品发布和扩张等有机战略,以扩大其全球影响力和产品组合,并满足日益增长的需求。

 

医用酶技术市场报告范围

报告属性细节
2020 年市场规模40.1亿美元
2028 年市场规模67亿美元
全球复合年增长率(2020 - 2028)6.7%
历史数据2018-2019
预测期2021-2028
涵盖的领域按酶类型
  • 消化酶
  • 溶栓酶
  • 水解酶
  • 核酸内切酶
按应用
  • 疾病治疗
  • 诊断工具
  • 生物医学研究
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 默克
  • 赛默飞世尔科技公司
  • 诺维信
  • 武田药品工业株式会社
  • 安捷伦科技公司
  • 丹纳赫(Cytiva)
  • 赛诺菲
  • 旭化成公司
  • 普洛麦格公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

按酶类型

  • 消化酶
  • L-天冬酰胺酶
  • 乳糖酶
  • 其他的
  • 溶栓酶
  • 链激酶
  • 尿激酶
  • 其他的
  • 水解酶
  • 透明质酸酶
  • 溶菌酶
  • 其他的
  • 核酸内切酶
  • 苯佐纳斯
  • 其他的

 

按应用

 

  • 疾病治疗
  • 诊断工具
  • 生物医学研究
  • 其他的

 

经过

地理

 

  • 北美

    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲

    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)

    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)

    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • MEA 其他地区
  • 南美洲和中美洲(SCAM)

    • 巴西
    • 阿根廷
    • 其余的骗局

 

公司简介

 

  • 默克
  • 赛默飞世尔科技公司
  • 诺维信
  • 武田药品工业株式会社
  • 安捷伦科技公司
  • 丹纳赫(Cytiva)
  • 赛诺菲
  • 旭化成公司
  • 普洛麦格公司
  • 天野酶株式会社
  • 健赞公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the cost of Medical Enzyme Technology?

The costs of the Medical Enzyme Technology are much higher, and they may cost US$ 5–50, or more, per enzyme type. The cost may also differ from product to product types.

What are the driving factors for the Medical Enzyme Technology market across the globe?

Key factors that are driving the market are advent of recombinant DNA technology, it has become possible to make formerly rare enzymes in large quantities and hence to reduce cost. Also, in pharmaceutical manufacturing, the desire to make chirally pure compounds is leading to new opportunities. Technological advances have facilitated the use of enzymes over an increasingly broad range of process conditions.

What are Medical Enzyme Technology?

Enzymes are proteins produced in living cells of plants, animals, and microorganisms. All living organisms require enzymes for growth and for the production and utilization of energy which is essential for life. In the living cell, enzymes act as catalysts to speed up the chemical reactions which control life processes. Enzymes have been significant industrial products for more than a hundred years. However, the range of potential applications is increasing rapidly.

The List of Companies - Medical Enzyme Technology Market

  1. Merck
  2. Thermo Fisher Scientific Inc.
  3. Novozymes
  4. TAKEDA PHARMACEUTICAL COMPANY LIMITED
  5. Agilent Technologies, Inc.
  6. Danaher (Cytiva)
  7. Sanofi
  8. Asahi Kasei Corporation
  9. Promega Corporation
  10. Amano Enzyme Inc
  11. Genzyme Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biotechnology : READ MORE..